Brief: Adaptive Biotechnologies Reports Second Quarter 2022 Financial Results
Aug 3 (Reuters) - Adaptive Biotechnologies Corp ADPT.O :
* ADAPTIVE BIOTECHNOLOGIES REPORTS SECOND QUARTER 2022
FINANCIAL
RESULTS
* Q2 REVENUE ROSE 13 PERCENT TO $43.7 MILLION
* ADAPTIVE BIOTECHNOLOGIES REITERATES FULL YEAR 2022 REVENUE
TO BE
IN RANGE OF $185 MILLION TO $195 MILLION.
* NOW EXPECT FULL YEAR 2022 OPERATING EXPENSES TO BE BETWEEN
$410
MILLION AND $415 MILLION
Source text for Eikon: ID:nGNX60kWM3
Further company coverage: ADPT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adaptive Biotechnologies
See all newsBrief: Adaptive Biotechnologies Corp - Issues $345 Million In 0% Convertible Senior Notes Due 2031 - SEC Filing
U.S. STOCKS ON THE MOVE-Jabil, BWX Technologies, Micron
U.S. STOCKS ON THE MOVE-Jabil, BWX Technologies, Micron
U.S. STOCKS ON THE MOVE-Intel, La-Z-Boy, CME
U.S. STOCKS ON THE MOVE-Intel, La-Z-Boy, AST SpaceMobile